Access cutting-edge high risk smoldering multiple myeloma (hr-smm) treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Atlanta location
Preparing your pre-screening questions…
Access high risk smoldering multiple myeloma (hr-smm) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related high risk smoldering multiple myeloma (hr-smm) treatment provided free
Check if you qualify for this high risk smoldering multiple myeloma (hr-smm) clinical trial in Atlanta, GA
No-Cost Study Care
Local to Atlanta
Convenient for GA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is researching an experimental drug called linvoseltamab (also called "study drug") compared to another drug called daratumumab, in participants with Smoldering Multiple Myeloma (SMM), who are at a High Risk (HR) of developing active multiple myeloma. The aim of this study is to find out whether linvoseltamab is better than daratumumab in delaying the development of MM. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
Sponsor: Regeneron Pharmaceuticals
Yes, this clinical trial (NCT07393282) has an active research site in Atlanta, GA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for high risk smoldering multiple myeloma (hr-smm) treatment options in Atlanta, GA, this clinical trial (NCT07393282) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced high risk smoldering multiple myeloma (hr-smm) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all high risk smoldering multiple myeloma (hr-smm) clinical trials near you to find additional studies recruiting in your area.
See all multiple myeloma clinical trials recruiting in Atlanta — not just this study.
Browse Multiple Myeloma Trials in Atlanta →